ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

NIH Study Finds Sigmoidoscopy Reduces Colon Cancer Incidence and Mortality Rates

May 25, 2012

How Much Is Life Worth? The $440 Billion Question

July 31, 2009

Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm

September 9, 2011

In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires

June 16, 1989

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006